#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15922	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2178	725.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1400	1400	C	948	C	844	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28986	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	819.3	0	.	n	.	0	T695C	SNP	695	695	T	1006	1006	C	887	C,T,A	799,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28986	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	819.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	1949	1949	G	955	G,T	859,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28986	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	819.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2282	2282	C	934	C	824	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28986	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	819.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2356	2356	A	923	A	849	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28986	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3528	819.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2908	2908	C	929	C,T	849,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1850	folP	855	855	100.0	folP.l15.c4.ctg.1	1418	130.1	1	SNP	p	R229S	1	.	.	685	687	AGC	959	961	AGC	180;181;181	A;G;C	159;159;158	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5892	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3480	168.8	1	SNP	p	S91F	1	.	.	271	273	TTC	630	632	TTC	176;177;176	T;T;C,T	158;159;156,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5892	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3480	168.8	1	SNP	p	G95N	0	.	.	283	285	GGC	642	644	GGC	178;177;174	G;G;C	157;160;156	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5892	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3480	168.8	1	SNP	p	D95G	1	.	.	283	285	GGC	642	644	GGC	178;177;174	G;G;C	157;160;156	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1652	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1430	115.3	1	SNP	p	G45D	0	.	.	133	135	GGC	502	504	GGC	205;206;205	G;G;C	187;189;190	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	832	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	880	93.6	0	.	n	.	0	A197.	DEL	197	197	A	513	513	A	204	A	183	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6604	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2782	236.0	1	SNP	p	D86N	0	.	.	256	258	GAC	516	518	GAC	262;262;262	G;A;C	234;233;234	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6604	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2782	236.0	1	SNP	p	S87R	1	.	.	259	261	CGT	519	521	CGT	267;259;258	C;G;T	240;235;228	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6604	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2782	236.0	1	SNP	p	R87I	0	.	.	259	261	CGT	519	521	CGT	267;259;258	C;G;T	240;235;228	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6604	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2782	236.0	1	SNP	p	R87W	0	.	.	259	261	CGT	519	521	CGT	267;259;258	C;G;T	240;235;228	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6604	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2782	236.0	1	SNP	p	S88P	0	.	.	262	264	TCC	522	524	TCC	261;260;261	T;C;C	232;232;233	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4184	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2423	171.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1441	1443	GGC	193;195;193	G;G;C	177;177;176	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2068	203.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1090	1092	GCC	206;205;206	G,C,T;C,T;C	182,1,1;180,1;182	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2068	203.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1093	1095	ATG	206;207;206	A;T;G	181;182;184	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2068	203.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1105	1107	ACC	202;197;197	A;C,T;C	176;178,1;178	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2068	203.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1105	1107	ACC	202;197;197	A;C,T;C	176;178,1;178	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2068	203.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1606	1608	ACC	247;246;247	A;C,T;C	219;229,1;229	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2068	203.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1660	1662	GCG	265;267;264	G;C;G	236;240;241	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2068	203.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1660	1662	GCG	265;267;264	G;C;G	236;240;241	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2068	203.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1783	1785	GGT	214;211;210	G;G;T	192;189;189	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2068	203.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1792	1794	AGC	205;200;202	A;G;C,T	183;178;184,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2068	203.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1810	1812	CCG	180;185;186	C,G;C;GCCC,GGGCCCCC	141,5;144;135,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6530	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3199	203.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1713	1715	CCG	227;227;231	C;C;G	202;206;206	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2308	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1755	130.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	555	555	C	147	C	134	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	297	91.03	porB1a.l6.c30.ctg.1	418	33.1	0	.	p	.	0	H217N	NONSYN	649	651	CAT	144	146	AAT	12;12;12	A;A;T	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	297	91.03	porB1a.l6.c30.ctg.1	418	33.1	0	.	p	.	0	D218N	NONSYN	652	654	GAT	147	149	AAT	12;11;11	A;A;T	12;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	297	91.03	porB1a.l6.c30.ctg.1	418	33.1	0	.	p	.	0	V226A	NONSYN	676	678	GTA	171	173	GCA	15;15;15	G;C;A	15;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	297	91.03	porB1a.l6.c30.ctg.1	418	33.1	0	.	p	.	0	.	MULTIPLE	700	702	ACT	194	196	GTA	15;16;16	G;T;A	15;16;16	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	342	porB1a	984	297	91.03	porB1a.l6.c30.ctg.1	418	33.1	0	.	p	.	0	N237fs	FSHIFT	709	709	A	203	203	A	17	A	17	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3346	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1684	197.9	1	SNP	p	G120K	1	.	.	358	360	AAG	668	670	AAG	254;256;258	A;A;G,A	226;233;224,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3346	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1684	197.9	1	SNP	p	A121N	1	.	.	361	363	AAC	671	673	AAC	256;256;252	A;A;C	232;228;225	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3346	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1684	197.9	1	SNP	p	N121D	0	.	.	361	363	AAC	671	673	AAC	256;256;252	A;A;C	232;228;225	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11960	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4847	246.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1356	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	982	137.4	1	SNP	p	V57M	1	.	.	169	171	ATG	503	505	ATG	287;290;291	A;T;G	266;266;270	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
